We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMER icon
9801
PUT
Omeros
OMER
$1.26B
$227K ﹤0.01%
100,500
-65,500
-39% -$181K
MYY icon
9802
ProShares Short MidCap400
MYY
$2.86M
$227K ﹤0.01%
9,135
-8,976
-50% -$225K
AMPH icon
9803
CALL
Amphastar Pharmaceuticals
AMPH
$887M
$227K ﹤0.01%
8,100
-13,100
-62% -$380K
FPI
9804
PUT
Farmland Partners
FPI
$427M
$227K ﹤0.01%
18,200
+6,300
+53% +$83.2K
CHKP icon
9805
Check Point Software Technologies
CHKP
$13B
$227K ﹤0.01%
1,797
-52,726
-97% -$6.58M
GOOD
9806
Gladstone Commercial Corp
GOOD
$628M
$227K ﹤0.01%
+12,253
New +$218K
NSLR
9807
PUT
Neostellar Capital Corp
NSLR
$275M
$227K ﹤0.01%
59,642
+6,466
+12% +$25.6K
GOSS icon
9808
PUT
Gossamer Bio
GOSS
$68.4M
$227K ﹤0.01%
104,400
+78,500
+303% +$646K
PDLB icon
9809
Ponce Financial Group
PDLB
$502M
$226K ﹤0.01%
24,288
+10,926
+82% +$104K
EDC icon
9810
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$173M
$226K ﹤0.01%
+7,700
New +$210K
POWW icon
9811
PUT
Outdoor Holding Co
POWW
$258M
$226K ﹤0.01%
130,800
-86,800
-40% -$219K
XDNA
9812
DELISTED
Strategic Trust Kelly CRISPR & Gene Editing Technology ETF
XDNA
$226K ﹤0.01%
22,756
-1,455
-6% -$16.3K
BCOV
9813
DELISTED
Brightcove, Inc.
BCOV
$226K ﹤0.01%
43,241
-8,884
-17% -$51.8K
BNDC icon
9814
FlexShares Core Select Bond Fund
BNDC
$170M
$226K ﹤0.01%
+10,302
New +$225K
APRN
9815
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$226K ﹤0.01%
22,642
-9,691
-30% -$183K
VERI icon
9816
Veritone
VERI
$108M
$225K ﹤0.01%
42,533
+29,686
+231% +$190K
CMBM
9817
CALL
DELISTED
Cambium Networks
CMBM
$225K ﹤0.01%
10,400
-20,600
-66% -$415K
CCEC
9818
PUT
Capital Clean Energy Carriers
CCEC
$1.37B
$225K ﹤0.01%
16,500
-11,600
-41% -$167K
VKTX icon
9819
Viking Therapeutics
VKTX
$3.92B
$225K ﹤0.01%
23,956
-28,291
-54% -$126K
NOBL icon
9820
PUT
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
$225K ﹤0.01%
5,000
-15,200
-75% -$676K
ADAM
9821
CALL
Adamas Trust
ADAM
$910M
$225K ﹤0.01%
21,950
-4,525
-17% -$48.2K
ARGT icon
9822
Global X MSCI Argentina ETF
ARGT
$801M
$225K ﹤0.01%
+6,613
New +$207K
ACET icon
9823
CALL
Adicet Bio
ACET
$81.8M
$224K ﹤0.01%
1,569
+919
+141% +$229K
SAR icon
9824
PUT
Saratoga Investment
SAR
$301M
$224K ﹤0.01%
+8,800
New +$210K
FONR
9825
DELISTED
Fonar
FONR
$224K ﹤0.01%
+13,387
New +$225K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.